SM

Sabby Management Portfolio holdings

AUM $13M
This Quarter Return
+2.36%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$186M
AUM Growth
–
Cap. Flow
+$186M
Cap. Flow %
100%
Top 10 Hldgs %
75.27%
Holding
107
New
46
Increased
–
Reduced
–
Closed
–

Top Buys

1
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
$37.6M
2
SRPT icon
Sarepta Therapeutics
SRPT
$17.3M
3
ABBV icon
AbbVie
ABBV
$14.7M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
$14.6M
5
ZTS icon
Zoetis
ZTS
$14.2M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 86.27%
2 Energy 0.58%
3 Consumer Staples 0%
4 Industrials 0%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SGYPW
51
DELISTED
Synergy Pharmaceuticals, Inc. - Warrants
SGYPW
– –
0
– –
ALXA
52
DELISTED
ALEXZA PHARMACEUTICALS INC COM STK NEW (DE)
ALXA
– –
0
– –
ALGN icon
53
Align Technology
ALGN
$9.59B
– –
0
– –
CERS icon
54
Cerus
CERS
$251M
– –
0
– –
CPRT icon
55
Copart
CPRT
$46.5B
– –
0
– –
ELV icon
56
Elevance Health
ELV
$72.4B
– –
0
– –
EW icon
57
Edwards Lifesciences
EW
$47.7B
– –
0
– –
EXEL icon
58
Exelixis
EXEL
$9.95B
– –
0
– –
FBIO icon
59
Fortress Biotech
FBIO
$87.8M
– –
0
– –
GYRE icon
60
Gyre Therapeutics
GYRE
$734M
– –
0
– –
IMNN icon
61
Imunon
IMNN
$14.4M
– –
0
– –
INCY icon
62
Incyte
INCY
$17B
– –
0
– –
INSM icon
63
Insmed
INSM
$30.3B
– –
0
– –
INVA icon
64
Innoviva
INVA
$1.32B
– –
0
– –
IONS icon
65
Ionis Pharmaceuticals
IONS
$9.64B
– –
0
– –
IWM icon
66
iShares Russell 2000 ETF
IWM
$66.6B
– –
0
– –
MRK icon
67
Merck
MRK
$210B
– –
0
– –
MYGN icon
68
Myriad Genetics
MYGN
$633M
– –
0
– –
NBIX icon
69
Neurocrine Biosciences
NBIX
$13.5B
– –
0
– –
OEF icon
70
iShares S&P 100 ETF
OEF
$22.1B
– –
0
– –
OPK icon
71
Opko Health
OPK
$1.1B
– –
0
– –
PBF icon
72
PBF Energy
PBF
$3.22B
– –
0
– –
PRGO icon
73
Perrigo
PRGO
$3.21B
– –
0
– –
REGN icon
74
Regeneron Pharmaceuticals
REGN
$59.8B
– –
0
– –
RMTI icon
75
Rockwell Medical
RMTI
$59.6M
– –
0
– –
1 2
3
4 5